Conference Coverage

Bariatric surgery tied to 22% lower 5-year stroke risk


 

FROM ASMBS 2021

‘Important,’ ‘good news’ for stroke risk after bariatric surgery

The impact of bariatric surgery on remission of type 2 diabetes is well known, Dr. Williams noted, and other studies have reported how bariatric surgery affects the risk of major adverse cardiovascular events – a composite of stroke, myocardial infarction, coronary artery disease, and all-cause death – including a study presented in the same meeting session.

However, a very large sample size is needed to be able to demonstrate the effect of bariatric surgery on stroke, since stroke is a rare event.

The researchers analyzed data from the Mariner (PearlDiver.) all-payer insurance national claims database of patients in the United States.

They matched 56,514 patients with a body mass index over 35 kg/m2 and comorbidities or a BMI of more than 40 who underwent sleeve gastrectomy or Roux-en-Y gastric bypass during 2010-2019 with 56,514 control patients who did not undergo bariatric surgery.

A year after bariatric surgery, patients in that group had a lower stroke rate than patients in the control group (0.6% vs. 1.2%), and they had close to 50% lower odds of having a stroke (odds ratio, 0.54; 95% CI, 0.47-0.61).

Three years after bariatric surgery, there were 44,948 patients in each group; the rate of stroke was 2.1% in the surgery group and 2.2% in the control group, and there was no significant difference in the odds of having a stroke (OR, 0.96; 95% CI, 0.91-1.00).

Five years after bariatric surgery, there were 27,619 patients in each group; the stroke rate was lower in the bariatric surgery group than in the control group (2.8% vs 3.6%), but reduced odds of stroke was not as great as after 1 year (OR, 0.78; 95% CI, 0.65-0.90).

Dr. Williams has no relevant financial disclosures. Dr. McBride and Dr. Scott disclosed that they are speakers/trainers/faculty advisers for Gore. Dr. Scott is also a consultant for C-SATS (part of Johnson & Johnson).

Pages

Recommended Reading

Pericardial fat an independent risk factor for heart failure
Journal of Clinical Outcomes Management
FDA approves ‘game changer’ semaglutide for weight loss
Journal of Clinical Outcomes Management
New obesity target? Dopamine circuit in brainstem affects satiety
Journal of Clinical Outcomes Management
Waist circumference a marker for NAFL in type 1 diabetes
Journal of Clinical Outcomes Management
Obesity amplifies harmful effects of alcohol on the liver
Journal of Clinical Outcomes Management
‘Twincretin’ meets primary endpoints in five pivotal diabetes trials
Journal of Clinical Outcomes Management
FDA: More metformin extended-release tablets recalled
Journal of Clinical Outcomes Management
Bariatric surgery tied to fewer HFpEF hospitalizations
Journal of Clinical Outcomes Management
Healthy with obesity? The latest study casts doubt
Journal of Clinical Outcomes Management
Bariatric surgery cuts insulin needs in type 1 diabetes with severe obesity
Journal of Clinical Outcomes Management